Inhibitor Therapeutics (INTI) Accounts Payables (2012 - 2026)
Inhibitor Therapeutics' Accounts Payables was $139,052 in Q2 2026, up 30.9% from $106,249 a year earlier but down 56.5% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Accounts Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Inhibitor Therapeutics came in at $51,521, up 224.1% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of -28.2% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $15,896 in FY2024 (-52.9%), $33,731 in FY2023 (-76.8%), $145,161 in FY2022 (-48.1%) and $279,842 in FY2021 (+3.9%).
- Quarterly Accounts Payables has moved between $1,706 (Q3 2024) and $326,464 (Q3 2022) over five years.
- Compared with a year earlier, Accounts Payables has increased for three straight quarters, with growth averaging 181.9% over the last seven quarters.
- The best year-over-year quarter for Accounts Payables over five years was Q1 2026 (growth of 771.4%); the worst was Q1 2023 (a decline of 98.4%).
- Per Business Quant data, INTI's Accounts Payables in the three quarters before Q2 2026 was $319,803 (Q1 2026), $51,521 (Q4 2025) and $19,646 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 139,052.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139,052.00 |
| Mar 31, 2026 | 319,803.00 |
| Dec 31, 2025 | 51,521.00 |
| Sep 30, 2025 | 19,646.00 |
| Jun 30, 2025 | 106,249.00 |
| Mar 31, 2025 | 36,702.00 |
| Dec 31, 2024 | 15,896.00 |
| Sep 30, 2024 | 1,706.00 |
| Jun 30, 2024 | 18,803.00 |
| Mar 31, 2024 | 111,916.00 |
| Dec 31, 2023 | 33,731.00 |
| Sep 30, 2023 | 93,147.00 |
| Jun 30, 2023 | 11,750.00 |
| Mar 31, 2023 | 5,007.00 |
| Dec 31, 2022 | 145,161.00 |
| Sep 30, 2022 | 326,464.00 |
| Jun 30, 2022 | 311,878.00 |
| Mar 31, 2022 | 321,701.00 |
| Dec 31, 2021 | 279,842.00 |
| Sep 30, 2021 | 304,820.00 |
API Access
Inhibitor Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();